Oaktop Capital Management Ii, L.P. Bristol Myers Squibb CO Transaction History
Oaktop Capital Management Ii, L.P.
- $916 Million
- Q3 2024
A detailed history of Oaktop Capital Management Ii, L.P. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Oaktop Capital Management Ii, L.P. holds 479,991 shares of BMY stock, worth $27.4 Million. This represents 2.71% of its overall portfolio holdings.
Number of Shares
479,991
Previous 679,991
29.41%
Holding current value
$27.4 Million
Previous $28.2 Million
12.04%
% of portfolio
2.71%
Previous 2.89%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,553Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.05 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.3 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.45 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.48 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $121B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...